Summary
Overview
Work History
Education
Affiliations
Timeline
Generic

MANASI MASHRU

Summary

Visionary and results-driven commercial leader with 20+ years of global experience advising Fortune 100 companies across Life Sciences, Consumer Health, Retail, Singapore Inc., and Technology. Proven track record in scaling P&Ls, driving innovation-enabled transformations, and shaping finance, risk, and governance strategies. Trusted advisor to CEOs and Boards, recognized for designing future-ready commercial strategies and operating models that deliver sustainable growth, build enterprise resilience, and develop high-performing leadership teams across APAC, EMEA, and the Americas.

Overview

21
21
years of professional experience

Work History

Managing Director & Practice Lead, Life Sciences & Consumer Health (Strategy & Consulting); Client Account Lead

Accenture – South East Asia (SEA)
02.2022 - Current

Managed dual P&L accountability: (1) $15M+ strategy portfolio and (2) Client Account Lead > $50M across two priority accounts.


Strategy & Consulting Practice Lead, Life Sciences & Consumer Health

  • Established and scaled the practice from ground up, defining vision, GTM strategy, and KPIs; drove ~4 years of growth ($300K – $22M+ sales) by creating innovative offerings, executing on global best practices, and building trusted C-suite relationships.
  • Led, grew & equipped a high-performing team of 50+, delivering “where to play/how to win” strategies, Go-To-Market (GTM) blueprints, launch excellence programs, and operating model redesigns, unlocking margin expansion, efficiency gains, and accelerated market penetration.
  • Co-launched a 170+ FTE LS capability hub (KL), enabling ~$40M+ in services annually and providing end-to-end transformation support.


Client Account Lead

  • Owned C-suite relationships for two priority accounts; a Fortune 500 (rev > $60B) and a FTSE 100 (rev > $30B) driving growth, full P&L accountability, and delivering measurable 360 client impact.
  • Partnered with Microsoft, Salesforce, and Google to pilot AI and digital use cases, converting disruptive innovations into tangible client value and competitive advantage.
  • Advised Leadership Committees on business performance, talent, and culture, channeling global expertise to accelerate outcomes and embed transformation.


Relevant Experience Across Portfolio

  • Market Growth & GTM Strategy: Unlocked 5-7% sales growth by diagnosing root causes and defining where-to-play/how-to-win priorities. Shaped and operationalized a growth blueprint that boosted brand awareness (+40%) and accelerated HCP adoption.
  • Omnichannel Reinvention: Led the commercial reinvention across 3 therapeutic areas and 500+ brand/market combinations, delivering a scalable omnichannel execution blueprint that lifted market share (+15%), tripled digital engagement in 18 months, and boosted brand visibility (+75%) across 19 Emerging Markets.
  • Salesforce Excellence: Led strategy, ROI case and execution for a GenAI-powered Sales Coach app, creating a Salesforce Excellence framework that accelerated onboarding (+30%), improved HCP engagement (>100+ territories), and enabled accelerated product launches.
  • Launch Playbook: Designed and executed a fit for growth vaccines launch playbook with targeted Route-To-Market strategy for 10 APAC markets, using digital transformation levers to reach >50M patients, and build a repeatable model for high-margin launches across assets.
  • Go-To-Market Optimization: Redesigned GTM strategy across Indonesia, Thailand, and Korea with new market entry, innovative channel playbooks, and capability uplift; delivering 1.5–2x profitable service-led sales growth in 3 years at ~40% EBIT.
  • Workforce of the Future: Designed workforce and talent strategy, embedding digital transformation initiatives that drove +20% employee engagement, +15% patient satisfaction, and improved operational efficiency.
  • Capability Building at Scale: Built an APAC-wide program for 400+ Patient Journey Partners across 35 cohorts in 5 regions, strengthening consultative & negotiation skills (+25% confidence) and accelerating delivery of transformative medicines.
  • M&A & Integration: Led $70M acquisition (100% buy-out) of a subsidiary (350 employees), overseeing valuation, diligence, and negotiations. Drove seamless integration, EBITDA uplift, and regional service expansion.
  • Leadership Reinvention: Designed and delivered a global leadership reinvention program (6 workshops) that aligned leaders on critical priorities, drove behavioral shifts to break silos, and elevated engagement; unlocking above-market commercial growth

Executive Director, Finance & Risk Advisory; Sector Lead, Life Sciences, Retail, Consumer & Singapore Inc Conglomerates

EY (Ernst & Young) – South East Asia (SEA)
10.2018 - 12.2021
  • Trusted Finance & Risk Advisory to Boards, Tech, Audit & Risk Committees of Fortune 500s, Temasek portfolio companies, and Singapore Inc institutions; strengthening functions, governance, resilience, and long-term enterprise value.
  • Partnered with CFOs to redesign finance functions and lead large-scale transformations, including IPO readiness, enterprise risk management, and process re-design of efficiency, digitization, and agility; delivering >30% productivity gains and $50M+ in savings.
  • Scaled EY’s Retail & Consumer practice in SEA, advising CXOs and CFOs on growth strategy, market entry, customer engagement & analytics, and embedding innovation-by-design into operating models across 7+ markets.


Relevant Experience Across Portfolio


  • IPO Readiness: Assessed and shaped enterprise finance, risk and governance structures alongside founders, enabling one of Southeast Asia’s largest IPOs (Tech Unicorn) and setting benchmarks for market readiness and compliance.
  • Finance, HR & Tech Shared Services: Redesigned enterprise finance, HR & Tech verticals, optimizing $45M cost base and setting up shared services. Delivered $7M (16%) savings and >30% productivity uplift (Temasek linked enterprise).
  • Customer Experience & Operational Excellence: Orchestrated transformation across 8 hospitals, improving turnaround times (-20–30%), reducing leakage, and enabling insight-driven decisions that lifted patient satisfaction & revenue capture.
  • Enterprise Finance Transformation: Led a $20M, 3-year Board-sponsored program, building data-driven risk insights and strengthening enterprise-wide risk capabilities to reduce exposure and drive resilience.
  • Commodities & Treasury Management (CTRM) Digital Transformation: Led 50+ FTE team to design digital trading & finance strategy, assessed & implemented a CTRM solution that automated processes, boosted operational efficiency (+30%), and enhanced risk visibility.

Senior Principal

EY | UKI & EU
01.2011 - 10.2018
  • M&A integration: Spearheaded a $2B acquisition, harmonizing commercial operations across 7 countries and realizing targeted synergies.
  • Finance Business Transformation: Orchestrated a global multi-country SAP rollout in partnership with the CFO and Transformation Head, delivering standardized processes, enhanced financial transparency, and operational efficiency to enable scalable growth.
  • Zero Based Budgeting: Developed cost to serve models for a retail company to enhance decision making and profitability; directly contributing to 10% reduction of costs.

Manager

EY | US
05.2005 - 12.2010
  • Managed and delivered strategy and consulting engagements across US focused on Health Insurance, Consumer & Retail covering business case, commercial due diligence, portfolio strategy, market entry, customer engagement and pricing models.

Co-Founder

OpenCL.com | US
05.2004 - 05.2005
  • Co-founded a university-based consulting firm, mobilizing teams of MBA and PhD students to deliver innovative, out-of-the-box solutions to client problems; successfully ran for 2 years.

Education

BACHELOR’S DEGREE - Economics, Management Information Systems

University of Wisconsin – Madison
05-2004

Affiliations

  • Board Member, Bonbillo Impact Accelerator: Driving growth and innovation for a global accelerator fund supporting social, cultural, and sustainability-focused ventures.
  • Recognition for Championing Women in Leadership: Honored for advancing gender diversity and creating pathways for working mothers to rise into leadership.
  • Value 360 Award Nominee (x2): Global Accenture recognition for delivering client growth, innovation, and sustainable impact.
  • ASEAN Executive Sponsor, Accenture C-Level Engagement (CLE) Academy: Designed and led a curriculum to elevate 300+ senior leaders’ C-suite presence, enabling trusted advisor positioning, impactful client dialogues, and board-level influence.
  • Nominated to the EY Entrepreneur of the Year APAC Committee: Entrusted with interviewing 20 entrepreneurs and industry leaders for selection through entrepreneurial insight and executive judgment
  • Affiliations: American Chamber of Commerce (AmCham), Asia Pacific MedTech Council (APACMed), Ascend (US Women Leadership Network), 30% Club, CriticalEYE

Timeline

Managing Director & Practice Lead, Life Sciences & Consumer Health (Strategy & Consulting); Client Account Lead

Accenture – South East Asia (SEA)
02.2022 - Current

Executive Director, Finance & Risk Advisory; Sector Lead, Life Sciences, Retail, Consumer & Singapore Inc Conglomerates

EY (Ernst & Young) – South East Asia (SEA)
10.2018 - 12.2021

Senior Principal

EY | UKI & EU
01.2011 - 10.2018

Manager

EY | US
05.2005 - 12.2010

Co-Founder

OpenCL.com | US
05.2004 - 05.2005

BACHELOR’S DEGREE - Economics, Management Information Systems

University of Wisconsin – Madison
MANASI MASHRU